Anti-IFNL2/ IL-28A/ IL28A functional antibody

Anti-IFNL2/ IL-28A/ IL28A functional antibody for cell culture, ELISA & in-vivo assay

Target products collectionGo to IFNL2/IFNL2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-SE0278-Ab-1/ GM-Tg-hg-SE0278-Ab-2Anti-Human IFNL2 monoclonal antibodyHuman
GM-Tg-rg-SE0278-Ab-1/ GM-Tg-rg-SE0278-Ab-2Anti-Rat IFNL2 monoclonal antibodyRat
GM-Tg-mg-SE0278-Ab-1/ GM-Tg-mg-SE0278-Ab-2Anti-Mouse IFNL2 monoclonal antibodyMouse
GM-Tg-cynog-SE0278-Ab-1/ GM-Tg-cynog-SE0278-Ab-2Anti-Cynomolgus/ Rhesus macaque IFNL2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-SE0278-Ab-1/ GM-Tg-felg-SE0278-Ab-2Anti-Feline IFNL2 monoclonal antibodyFeline
GM-Tg-cang-SE0278-Ab-1/ GM-Tg-cang-SE0278-Ab-2Anti-Canine IFNL2 monoclonal antibodyCanine
GM-Tg-bovg-SE0278-Ab-1/ GM-Tg-bovg-SE0278-Ab-2Anti-Bovine IFNL2 monoclonal antibodyBovine
GM-Tg-equg-SE0278-Ab-1/ GM-Tg-equg-SE0278-Ab-2Anti-Equine IFNL2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-SE0278-Ab-1/ GM-Tg-hg-SE0278-Ab-2; GM-Tg-rg-SE0278-Ab-1/ GM-Tg-rg-SE0278-Ab-2;
GM-Tg-mg-SE0278-Ab-1/ GM-Tg-mg-SE0278-Ab-2; GM-Tg-cynog-SE0278-Ab-1/ GM-Tg-cynog-SE0278-Ab-2;
GM-Tg-felg-SE0278-Ab-1/ GM-Tg-felg-SE0278-Ab-2; GM-Tg-cang-SE0278-Ab-1/ GM-Tg-cang-SE0278-Ab-2;
GM-Tg-bovg-SE0278-Ab-1/ GM-Tg-bovg-SE0278-Ab-2; GM-Tg-equg-SE0278-Ab-1/ GM-Tg-equg-SE0278-Ab-2
Products NameAnti-IFNL2 monoclonal antibody
Formatmab
Target NameIFNL2
Protein Sub-locationSecreted Protein/Potential Cytokines
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-IFNL2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-SE0278-Ag-1Recombinant multi-species IFNL2/ IL-28A/ IL28A protein


    Target information

    Target IDGM-SE0278
    Target NameIFNL2
    Gene ID282616
    Gene Symbol and SynonymsIFNL2,IFNL2a,IFNL3a,IL-28A,IL28A
    Uniprot AccessionQ8IZJ0
    Uniprot Entry NameIFNL2_HUMAN
    Protein Sub-locationSecreted Protein/Potential Cytokines
    Category
    DiseaseN/A
    Gene EnsemblENSG00000183709
    Target ClassificationN/A

    The target: IFNL2, gene name: IFNL2, also named as IL-28A, IL28A. This gene encodes a cytokine distantly related to type I interferons and the IL-10 family. This gene, interleukin 28B (IL28B), and interleukin 29 (IL29) are three closely related cytokine genes that form a cytokine gene cluster on a chromosomal region mapped to 19q13. Expression of the cytokines encoded by the three genes can be induced by viral infection. All three cytokines have been shown to interact with a heterodimeric class II cytokine receptor that consists of interleukin 10 receptor, beta (IL10RB) and interleukin 28 receptor, alpha (IL28RA). [provided by RefSeq, Jul 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.